Real-time enrollment status for this hepatocellular carcinoma clinical trial
Current Status
Recruiting
Checked: August 25, 2026 at 7:09 PM UTC
| NCT Number | NCT06084481 |
| Recruiting Status | Recruiting |
| Condition | Hepatocellular Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 325 participants |
| Active Locations | 20 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | August 24, 2026 (Yesterday) |
As of August 25, 2026: Clinical trial NCT06084481 is currently recruiting participants. This phase1 study for hepatocellular carcinoma is actively seeking new participants at 20 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06084481 is actively recruiting participants as of August 25, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06084481 was last updated Yesterday (August 24, 2026). HelloStudys verifies this status automatically.